Its an important step that can help ensure youre getting the right dose of your medication
The issue of obesity and insulin resistance prompted the design of a number of studies investigating the effects of antidiabetic drugs in PCOS, as reported in recent and very exhaustive reviews on the available clinical trials on glucagon-like peptide 1 receptor agonists (GLP-1RA) in PCOS [21, 23, 24]
A qualitative exploration of postoperative bariatric patients' psychosocial support for long-term weight loss and psychological wellbeing
Furthermore, the GLP-1RA group lowered blood glucose additionally during weight loss maintenance in contrast to the control group where blood glucose levels increased to the same level as before the weight loss even though the weight loss was maintained
"As part of an extension trial published a year later, participants regained an average of two-thirds of the weight they shed within 12 months of discontinuing the drug." Within 12 months of discontinuing the drug, participants regained an average of two-thirds of the weight they shed
